Skip to main content
Premium Trial:

Request an Annual Quote

Debiopharm Group Taps Quartz Bio to Provide Bioinformatics Support for Biomarker Projects

Premium

Last week, Quartz Bio said that it had been selected to provide bioinformatics support for biomarker projects conducted by the Debiopharm group, a Swiss-based biopharmaceutical company.

Under the terms of the one-year agreement, the Merck Serono spinoff (BI 9/7/2012) will provide computational analyses for Debiopharm projects in areas such as preclinical next-generation sequencing and clinical biomarker data analyses.

The financial details of the deal are not being disclosed.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.